The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Soft Tissue Infections

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Soft Tissue Infections


Psychiatry related information on Soft Tissue Infections

  • A randomized, double-blind trial compared the clinical and bacteriologic efficacy of ampicillin/sulbactam (2 g/1 g) and cefoxitin (2 g) administered intravenously every 6 h to patients with (n=49) or without (n=47) histories of injection drug abuse who presented with cutaneous or other soft-tissue infections [6].

High impact information on Soft Tissue Infections


Chemical compound and disease context of Soft Tissue Infections


Biological context of Soft Tissue Infections


Anatomical context of Soft Tissue Infections


Gene context of Soft Tissue Infections


Analytical, diagnostic and therapeutic context of Soft Tissue Infections


  1. Invasive soft tissue infections with Streptococcus pneumoniae in patients with systemic lupus erythematosus: case report and review of the literature. Hill, M.D., Karsh, J. Arthritis Rheum. (1997) [Pubmed]
  2. Group A beta-hemolytic streptococcal bacteremia and intravenous substance abuse. A growing clinical problem? Lentnek, A.L., Giger, O., O'Rourke, E. Arch. Intern. Med. (1990) [Pubmed]
  3. Molecular analysis of the role of streptococcal pyrogenic Exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes. Sriskandan, S., Unnikrishnan, M., Krausz, T., Cohen, J. Mol. Microbiol. (1999) [Pubmed]
  4. Comparison of ticarcillin plus clavulanic acid with cefoxitin in the treatment of female pelvic infection. Pastorek, J.G., Aldridge, K.E., Cunningham, G.L., Faro, S., Graffeo, S., McNeeley, G.S., Tan, J.S. Am. J. Med. (1985) [Pubmed]
  5. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment. Becker, W., Bair, J., Behr, T., Repp, R., Streckenbach, H., Beck, H., Gramatzki, M., Winship, M.J., Goldenberg, D.M., Wolf, F. J. Nucl. Med. (1994) [Pubmed]
  6. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse. Talan, D.A., Summanen, P.H., Finegold, S.M. Clin. Infect. Dis. (2000) [Pubmed]
  7. Erythromycin for anaerobic pleuropulmonary and soft-tissue infections. Goldstein, E.J., Lewis, R.P., Sutter, V.L., Finegold, S.M. JAMA (1979) [Pubmed]
  8. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. Ashbaugh, C.D., Warren, H.B., Carey, V.J., Wessels, M.R. J. Clin. Invest. (1998) [Pubmed]
  9. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. Schrager, H.M., Rheinwald, J.G., Wessels, M.R. J. Clin. Invest. (1996) [Pubmed]
  10. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Seymour, J.F., Lieschke, G.J., Grail, D., Quilici, C., Hodgson, G., Dunn, A.R. Blood (1997) [Pubmed]
  11. Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial. Naamara, W., Plummer, F.A., Greenblatt, R.M., D'Costa, L.J., Ndinya-Achola, J.O., Ronald, A.R. Am. J. Med. (1987) [Pubmed]
  12. Treatment of skin and soft tissue infections with imipenem/cilastatin. Fass, R.J., Freimer, E.H., McCloskey, R.V. Am. J. Med. (1985) [Pubmed]
  13. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen. Bradsher, R.W., Snow, R.M. Am. J. Med. (1984) [Pubmed]
  14. Efficacy of intravenous clindamycin and methicillin in gram-positive soft tissue infections. Chessick, K.C., Begley, L.A., Curtis, L.E., Hirsch, E.F., Kaiser, C.W., Burek, C.A., Soroff, H.S. Ann. Surg. (1975) [Pubmed]
  15. Noncomparative trial of ticarcillin plus clavulanic acid in skin and soft tissue infections. LeFrock, J.L., Johnson, E.S., Smith, L.G., Rosenberg, E. Am. J. Med. (1985) [Pubmed]
  16. Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function. Pietroski, N.A., Graziani, A.L., Lawson, L.A., Bland, J.A., Rogers, J.D., MacGregor, R.R. Antimicrob. Agents Chemother. (1991) [Pubmed]
  17. Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci. Pandiripally, V., Wei, L., Skerka, C., Zipfel, P.F., Cue, D. Infect. Immun. (2003) [Pubmed]
  18. Hydrolysis of chloramphenicol succinate in local treatment of soft tissue infections. Nilsson-Ehle, I., Hedström, S.A. J. Antimicrob. Chemother. (1987) [Pubmed]
  19. Treatment of soft tissue infections in gynecology by comparison 3 vs 7 day therapy with ciprofloxacin. Weissenhacher, E.R., Gotz, A., Braun, H., Gutschow, K., Wachter, I. Journal of chemotherapy (Florence, Italy) (1989) [Pubmed]
  20. Community-acquired methicillin-resistant Staphylococcus aureus infections. Maltezou, H.C., Giamarellou, H. Int. J. Antimicrob. Agents (2006) [Pubmed]
  21. Pharmacokinetics of fleroxacin as studied by positron emission tomography and [18F]fleroxacin. Rubin, R.H., Livni, E., Babich, J., Alpert, N.M., Liu, Y.Y., Tham, E., Prosser, B., Cleeland, R., Callahan, R.J., Correia, J.A. Am. J. Med. (1993) [Pubmed]
  22. Management of soft-tissue infections of the upper extremity in parenteral drug abusers. Biderman, P., Hiatt, J.R. Am. J. Surg. (1987) [Pubmed]
  23. Musculoskeletal sonography and MR imaging. A role for both imaging methods. Jacobson, J.A. Radiol. Clin. North Am. (1999) [Pubmed]
  24. Imipenem/cilastatin treatment of lower extremity skin and soft tissue infections in diabetics. Calandra, G.B., Raupp, W., Brown, K.R. Scandinavian journal of infectious diseases. Supplementum. (1987) [Pubmed]
  25. Soft tissue and cartilage infection by Salmonella oranienburg in a healthy girl. Porcalla, A.R., Rodriguez, W.J. South. Med. J. (2001) [Pubmed]
  26. Interferon gamma and tumor necrosis factor alpha. Use in gram-negative infection after shock. Malangoni, M.A., Livingston, D.H., Sonnenfeld, G., Polk, H.C. Archives of surgery (Chicago, Ill. : 1960) (1990) [Pubmed]
  27. Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infections. Hidalgo-Grass, C., Dan-Goor, M., Maly, A., Eran, Y., Kwinn, L.A., Nizet, V., Ravins, M., Jaffe, J., Peyser, A., Moses, A.E., Hanski, E. Lancet (2004) [Pubmed]
  28. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Nguyen, D.M., Mascola, L., Brancoft, E. Emerging Infect. Dis. (2005) [Pubmed]
  29. Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease. Joukhadar, C., Klein, N., Frossard, M., Minar, E., Stass, H., Lackner, E., Herrmann, M., Riedmüller, E., Müller, M. Clin. Pharmacol. Ther. (2001) [Pubmed]
  30. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. Goldstein, E.J., Citron, D.M., Hunt Gerardo, S., Hudspeth, M., Merriam, C.V. Antimicrob. Agents Chemother. (1998) [Pubmed]
  31. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections. Tassler, H. Am. J. Med. (1993) [Pubmed]
  32. Linezolid. Clemett, D., Markham, A. Drugs (2000) [Pubmed]
  33. Once-daily ceftriaxone for skin and soft tissue infections. Gordin, F.M., Wofsy, C.B., Mills, J. Antimicrob. Agents Chemother. (1985) [Pubmed]
  34. Ceftazidime in the therapy of serious Gram-negative bacillary infections. Pottage, J.C., Karakusis, P.H., Fliegelman, R.M., Levin, S., Trenholme, G.M. J. Antimicrob. Chemother. (1983) [Pubmed]
  35. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections. Stevens, D.L., Pien, F., Drehobl, M. Diagn. Microbiol. Infect. Dis. (1993) [Pubmed]
WikiGenes - Universities